Key players in the global topical pain management therapeutics in sports medicine market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global topical pain management therapeutics in sports medicine market. A few expansion strategies adopted by players operating in the global topical pain management therapeutics in sports medicine market are:
The report on the global topical pain management therapeutics in sports medicine market discussed individual strategies, followed by company profiles of manufacturers of topical pain management therapeutics in sports medicine. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global topical pain management therapeutics in sports medicine market.
Topical Pain Management Therapeutics in Sports Medicine Market - Outline
There has been an increasing focus on development of new routes of drug administration to provide tailored treatments for patients, without decreasing efficacy of analgesia, in proportion to the progression of the knowledge of pain mechanisms. While acute pain acts as an alarm, chronic pain is a syndrome requiring meticulous selection of analgesic drugs of high bioavailability for long-term use. Such criteria are challenges that topical medications aim to overcome, allowing progressive delivery of active component, maintaining stable plasma levels, with a good safety profile. This review presents recent findings regarding topical formulations of the most widely used drugs for pain treatment, such as nonsteroidal anti-inflammatory agents, anesthetics, and capsaicin, and the role of physical agents as delivery enhancers (phonophoresis and iontophoresis). Although the number of topical agents is limited for use in peripheral conditions, increasing evidence supports the efficacy of these preparations in blocking nociceptive and neuropathic pain. Patient adherence to medical treatment is also a challenge, especially in chronic painful conditions. It is known that reduction of treatment complexity and pill burden are good strategies to increase patient compliance.
Evidence based on empirical practice has suggested that topically applied medications can be almost as effective as those taken orally, with a good safety profile in terms of adverse effects. The ultimate goal that motivates the development of topical preparations is the improvement of patient compliance to medical treatment, by providing efficient pain relief with less central nervous system effects and minimal drug regimen burden.
The medicine or drugs which are applied locally on the area which is being treated is called as topical drugs. ‘Topikos’ in Greek means ‘at a place’. Many creams and ointments which are applied to skin are often called a topical drugs. Topical pain management therapeutics are specialty products that are used to relieve acute musculoskeletal pain or general sprains or strains.
The therapeutics involve various drug classes such as analgesics, anesthetics, and skeletal muscle relaxants. Topical pain relievers are becoming increasingly popular in sports category owing to their site-specific action, cost-effectiveness, instant pain relief, and availability in the OTC segment
Topical pain management therapeutics in sports medicine market to reach US$ 3,470.3 Mn by 2027
Topical pain management therapeutics in sports medicine market is anticipated to expand at a CAGR of 8.8% from 2019 to 2027
Topical pain management therapeutics in sports medicine market is driven by increase in incidence of musculoskeletal acute sports injuries
North America accounted for major share of the global topical pain management therapeutics in sports medicine market
Key players in the global topical pain management therapeutics in sports medicine market are Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Hisamitsu Pharmaceutical Co., Inc., Mayne Pharma Group Limited, Sanofi (Chattem, Inc.)
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Topical Pain Management Therapeutics in Sports Medicine Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Patch Design Technologies: Snapshot Regulatory Scenario, by Region/Globally
5.2. WHO’s Pain Relief Ladder
6. Global Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.1.1. Key Findings / Developments
6.2. Global Topical Pain Management Therapeutics in Sports Medicine Market Value Forecast, by Product, 2017–2027
6.2.1. Gels
6.2.2. Creams
6.2.3. Patches
6.2.3.1. Drug in Adhesives
6.2.3.2. Matrix
6.2.3.3. Reservoirs
6.2.3.4. Others
6.3. Global Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product
7. Global Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast, by Therapeutic Class
7.1. Introduction & Definition
7.1.1. Key Findings / Developments
7.2. Global Topical Pain Management Therapeutics in Sports Medicine Market Value Forecast, by Therapeutic Class, 2017–2027
7.2.1. Analgesics
7.2.1.1. Opioids
7.2.1.1.1. Fentanyl
7.2.1.1.2. Buprenorphine
7.2.1.1.3. Others
7.2.1.2. Non-opioids
7.2.1.2.1. Lidocaine
7.2.1.2.2. Diclofenac
7.2.1.2.3. Capsaicin
7.2.1.2.4. Methyl Salicylate
7.2.1.2.5. Others
7.2.2. Anesthetics
7.2.3. Skeletal Muscle Relaxants
7.3. Global Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Therapeutic Class
8. Global Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Topical Pain Management Therapeutics in Sports Medicine Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. North America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Region
9. North America Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. North America Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Product, 2017–2027
9.2.1. Gels
9.2.2. Creams
9.2.3. Patches
9.2.3.1. Drug in Adhesives
9.2.3.2. Matrix
9.2.3.3. Reservoirs
9.2.3.4. Others
9.3. North America Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Therapeutic Class, 2017–2027
9.3.1. Analgesics
9.3.1.1. Opioids
9.3.1.1.1. Fentanyl
9.3.1.1.2. Buprenorphine
9.3.1.1.3. Others
9.3.1.2. Non-opioids
9.3.1.2.1. Lidocaine
9.3.1.2.2. Diclofenac
9.3.1.2.3. Capsaicin
9.3.1.2.4. Methyl Salicylate
9.3.1.2.5. Others
9.3.2. Anesthetics
9.3.3. Skeletal Muscle Relaxants
9.4. North America Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Country, 2017–2027
9.4.1. U.S.
9.4.2. Canada
9.5. North America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By Therapeutic Class
9.5.3. By Country
10. Europe Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Europe Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Product, 2017–2027
10.2.1. Gels
10.2.2. Creams
10.2.3. Patches
10.2.3.1. Drug in Adhesives
10.2.3.2. Matrix
10.2.3.3. Reservoirs
10.2.3.4. Others
10.3. Europe Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Therapeutic Class, 2017–2027
10.3.1. Analgesics
10.3.1.1. Opioids
10.3.1.1.1. Fentanyl
10.3.1.1.2. Buprenorphine
10.3.1.1.3. Others
10.3.1.2. Non-opioids
10.3.1.2.1. Lidocaine
10.3.1.2.2. Diclofenac
10.3.1.2.3. Capsaicin
10.3.1.2.4. Methyl Salicylate
10.3.1.2.5. Others
10.3.2. Anesthetics
10.3.3. Skeletal Muscle Relaxants
10.4. Europe Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By Therapeutic Class
10.5.3. By Country/Sub-region
11. Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Product, 2017–2027
11.2.1. Gels
11.2.2. Creams
11.2.3. Patches
11.2.3.1. Drug in Adhesives
11.2.3.2. Matrix
11.2.3.3. Reservoirs
11.2.3.4. Others
11.3. Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Therapeutic Class, 2017–2027
11.3.1. Analgesics
11.3.1.1. Opioids
11.3.1.1.1. Fentanyl
11.3.1.1.2. Buprenorphine
11.3.1.1.3. Others
11.3.1.2. Non-opioids
11.3.1.2.1. Lidocaine
11.3.1.2.2. Diclofenac
11.3.1.2.3. Capsaicin
11.3.1.2.4. Methyl Salicylate
11.3.1.2.5. Others
11.3.2. Anesthetics
11.3.3. Skeletal Muscle Relaxants
11.4. Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By Therapeutic Class
11.5.3. By Country/Sub-region
12. Latin America Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Latin America Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Product, 2017–2027
12.2.1. Gels
12.2.2. Creams
12.2.3. Patches
12.2.3.1. Drug in Adhesives
12.2.3.2. Matrix
12.2.3.3. Reservoirs
12.2.3.4. Others
12.3. Latin America Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Therapeutic Class, 2017–2027
12.3.1. Analgesics
12.3.1.1. Opioids
12.3.1.1.1. Fentanyl
12.3.1.1.2. Buprenorphine
12.3.1.1.3. Others
12.3.1.2. Non-opioids
12.3.1.2.1. Lidocaine
12.3.1.2.2. Diclofenac
12.3.1.2.3. Capsaicin
12.3.1.2.4. Methyl Salicylate
12.3.1.2.5. Others
12.3.2. Anesthetics
12.3.3. Skeletal Muscle Relaxants
12.4. Latin America Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America Latin America
12.5. Latin America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By Therapeutic Class
12.5.3. By Country/Sub-region
13. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Product, 2017–2027
13.3. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Product, 2017–2027
13.3.1. Gels
13.3.2. Creams
13.3.3. Patches
13.3.3.1. Drug in Adhesives
13.3.3.2. Matrix
13.3.3.3. Reservoirs
13.3.3.4. Others
13.4. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Therapeutic Class, 2017–2027
13.4.1. Analgesics
13.4.1.1. Opioids
13.4.1.1.1. Fentanyl
13.4.1.1.2. Buprenorphine
13.4.1.1.3. Others
13.4.1.2. Non-opioids
13.4.1.2.1. Lidocaine
13.4.1.2.2. Diclofenac
13.4.1.2.3. Capsaicin
13.4.1.2.4. Methyl Salicylate
13.4.1.2.5. Others
13.4.2. Anesthetics
13.4.3. Skeletal Muscle Relaxants
13.5. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Therapeutic Class
13.6.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (by Tier and Size of companies)
14.2. Market Share / Position Analysis, by Company, 2018
14.3. Company Profiles
14.3.1. Teva Pharmaceutical Industries Ltd.
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Overview
14.3.1.3. Strategic Overview
14.3.1.4. SWOT Analysis
14.3.2. Pfizer, Inc.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Financial Overview
14.3.2.3. Strategic Overview
14.3.2.4. SWOT Analysis
14.3.3. Hisamitsu Pharmaceutical Co., Inc.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Overview
14.3.3.3. Strategic Overview
14.3.3.4. SWOT Analysis
14.3.4. Mayne Pharma Group Limited
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Financial Overview
14.3.4.3. Strategic Overview
14.3.4.4. SWOT Analysis
14.3.5. Chattem, Inc.
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Financial Overview
14.3.5.3. Strategic Overview
14.3.5.4. SWOT Analysis
14.3.6. GlaxoSmithKline plc.
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Financial Overview
14.3.6.3. Strategic Overview
14.3.6.4. SWOT Analysis
14.3.7. Endo Pharmaceuticals Inc.
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Financial Overview
14.3.7.3. Strategic Overview
14.3.7.4. SWOT Analysis
14.3.8. Beiersdorf AG
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Financial Overview
14.3.8.3. Strategic Overview
14.3.8.4. SWOT Analysis
14.3.9. Janssen Global Services, LLC
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Financial Overview
14.3.9.3. SWOT Analysis
14.3.10. Topical BioMedics, Inc.
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Strategic Overview
14.3.10.3. SWOT Analysis
List of Tables
Table 01: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2017–2027
Table 02: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2017–2027
Table 03: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2017–2027
Table 04: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2017–2027
Table 05: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2017–2027
Table 06: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2017–2027
Table 07: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Region, 2017–2027
Table 08: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Country, 2017–2027
Table 09: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2017–2027
Table 10: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2017–2027
Table 11: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2017–2027
Table 12: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2017–2027
Table 13: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2017–2027
Table 14: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2017–2027
Table 15: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Country, 2017–2027
Table 16: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2017–2027
Table 17: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2017–2027
Table 18: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2017–2027
Table 19: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2017–2027
Table 20: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2017–2027
Table 21: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2017–2027
Table 22: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Country, 2017–2027
Table 23: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2017–2027
Table 24: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2017–2027
Table 25: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2017–2027
Table 26: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2017–2027
Table 27: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2017–2027
Table 28: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2017–2027
Table 29: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Country, 2017–2027
Table 30: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2017–2027
Table 31: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2017–2027
Table 32: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2017–2027
Table 33: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2017–2027
Table 34: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2017–2027
Table 35: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2017–2027
Table 36: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Country, 2017–2027
Table 37: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2017–2027
Table 38: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2017–2027
Table 39: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2017–2027
Table 40: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2017–2027
Table 41: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2017–2027
Table 42: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2017–2027
List of Figures
Figure 01: Global Topical Pain Management Therapeutics in Sports Medicine Market Size (US$ Mn), CAGR and Share (%), by Geography, 2018 and 2027
Figure 02: Global Topical Pain Management Therapeutics in Sports Medicine Market Size (US$ Mn) Forecast, 2017–2027
Figure 03: Global Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Product, 2018
Figure 04: Global Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Therapeutic Class, 2018
Figure 05: Global Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Region, 2018
Figure 06: Global Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Product, 2018 and 2027
Figure 07: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Gels, 2017–2027
Figure 08: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Creams, 2017–2027
Figure 09: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Sprays, 2017–2027
Figure 10: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Patches, 2017–2027
Figure 11: Global Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product, 2017–2027
Figure 12: Global Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Therapeutic Class , 2018 and 2027
Figure 13: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Analgesics, 2017–2027
Figure 14: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Anesthetics, 2017–2027
Figure 15: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Skeletal Muscle Relaxants, 2017–2027
Figure 16: Global Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product, 2017–2027
Figure 17: Global Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Region, 2018 and 2027
Figure 18: Global Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Region, 2017–2027
Figure 19: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 20: North America Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Country, 2018 and 2027
Figure 21: North America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Country, 2017–2027
Figure 22: North America Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Product, 2018 and 2027
Figure 23: North America Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Therapeutic Class, 2018 and 2027
Figure 24: North America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product, 2018 and 2027
Figure 25: North America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Therapeutic Class, 2017–2027
Figure 26: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 27: Europe Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Country, 2018 and 2027
Figure 28: Europe Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Country, 2017–2027
Figure 29: Europe Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Product, 2018 and 2027
Figure 30: Europe Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Therapeutic Class, 2018 and 2027
Figure 31: Europe Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product, 2018 and 2027
Figure 32: Europe Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Therapeutic Class, 2017–2027
Figure 33: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027
Figure 34: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Country, 2018 and 2027
Figure 35: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Country, 2017–2027
Figure 36: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Product, 2018 and 2027
Figure 37: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Therapeutic Class, 2018 and 2027
Figure 38: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product, 2018 and 2027
Figure 39: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Therapeutic Class, 2017–2027
Figure 40: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027
Figure 41: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Country, 2018 and 2027
Figure 42: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Country, 2017–2027
Figure 43: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Product, 2018 and 2027
Figure 44: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Therapeutic Class, 2018 and 2027
Figure 45: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product, 2018 and 2027
Figure 46: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Therapeutic Class, 2017–2027
Figure 47: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 48: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Country, 2018 and 2027
Figure 49: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Country, 2017–2027
Figure 50: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Product, 2018 and 2027
Figure 51: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Therapeutic Class, 2018 and 2027
Figure 52: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product, 2018 and 2027
Figure 53: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Therapeutic Class, 2017–2027
Figure 54: Global Topical Pain Management Therapeutics in Sports Medicine Market Share (%) & Market Share Range (%), by Company, 2016
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Topical Pain Management Therapeutics in Sports Medicine Market
